person · Reporting owner
Kemula Pierre Thadee Victor
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AgomAb Therapeutics NVAGMB · Entity 5259 | Chief Financial Officer | October 06, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AgomAb Therapeutics NV
Report date October 06, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common sharesSEC Table I · non-derivative | Direct | 10,000 |
Last balance in matching sequence
After 2026-10-06 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-06 · Purchase · Acquired 3,000 · Balance 3,000 F1: The common shares may be represented by American Depositary Shares, each of which currently represents one common share. Row 2 · 2026-10-06 · Purchase · Acquired 5,000 · Balance 8,000 F1: The common shares may be represented by American Depositary Shares, each of which currently represents one common share. Row 3 · 2026-10-06 · Purchase · Acquired 2,000 · Balance 10,000 F1: The common shares may be represented by American Depositary Shares, each of which currently represents one common share. |
Filing footnotes · ownership attribution and instrument terms
F1: The common shares may be represented by American Depositary Shares, each of which currently represents one common share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 7, 2026 12:47 UTC | AgomAb Therapeutics NV AGMB · Entity 5259 | PurchaseCommon shares | 2,000 | $8.54 | $17,080.00 |
DisclosureSEC source: 0002119332-26-000001 · primary_doc.xml · nonDerivative · entry 3 Kemula Pierre Thadee Victor · CIK 0002119332 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 12:47 UTC | AgomAb Therapeutics NV AGMB · Entity 5259 | PurchaseCommon shares | 5,000 | $8.57 | $42,850.00 |
DisclosureSEC source: 0002119332-26-000001 · primary_doc.xml · nonDerivative · entry 2 Kemula Pierre Thadee Victor · CIK 0002119332 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 12:47 UTC | AgomAb Therapeutics NV AGMB · Entity 5259 | PurchaseCommon shares | 3,000 | $8.67 | $26,010.00 |
DisclosureSEC source: 0002119332-26-000001 · primary_doc.xml · nonDerivative · entry 1 Kemula Pierre Thadee Victor · CIK 0002119332 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 F1 · security: The common shares may be represented by American Depositary Shares, each of which currently represents one common share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.